These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 7533456)
1. Stability of serum prostate-specific antigen determination across laboratory, assay, and storage time. Jacobsen SJ; Klee GG; Lilja H; Wright GL; Oesterling JE Urology; 1995 Mar; 45(3):447-53. PubMed ID: 7533456 [TBL] [Abstract][Full Text] [Related]
2. An analytical comparison of the three most commonly used prostate-specific antigen assays: Tandem-R, Tandem-E, and IMx. Oesterling JE; Moyad MA; Wright GL; Beck GR Urology; 1995 Oct; 46(4):524-32. PubMed ID: 7571222 [TBL] [Abstract][Full Text] [Related]
3. Comparability of the Tandem-R and IMx assays for the measurement of serum prostate-specific antigen. Jacobsen SJ; Lilja H; Klee GG; Wright GL; Pettersson K; Oesterling JE Urology; 1994 Oct; 44(4):512-8. PubMed ID: 7524236 [TBL] [Abstract][Full Text] [Related]
4. Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasia. Paus E; Nilsson O; Børmer OP; Fosså SD; Otnes B; Skovlund E J Urol; 1998 May; 159(5):1599-605. PubMed ID: 9554362 [TBL] [Abstract][Full Text] [Related]
5. Ejaculation increases the serum prostate-specific antigen concentration. Tchetgen MB; Song JT; Strawderman M; Jacobsen SJ; Oesterling JE Urology; 1996 Apr; 47(4):511-6. PubMed ID: 8638359 [TBL] [Abstract][Full Text] [Related]
6. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma. Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461 [TBL] [Abstract][Full Text] [Related]
7. Early detection of recurrent prostate cancer with an ultrasensitive chemiluminescent prostate-specific antigen assay. Ellis WJ; Vessella RL; Noteboom JL; Lange PH; Wolfert RL; Rittenhouse HG Urology; 1997 Oct; 50(4):573-9. PubMed ID: 9338734 [TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer. Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094 [TBL] [Abstract][Full Text] [Related]
9. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men. Khezri AA; Shirazi M; Ayatollahi SM; Lotfi M; Askarian M; Ariafar A; Afrasiabi MA Iran J Immunol; 2009 Mar; 6(1):40-8. PubMed ID: 19293477 [TBL] [Abstract][Full Text] [Related]
10. Detection of residual prostate cancer after radical prostatectomy with the Abbott IMx PSA assay. Schild SE; Wong WW; Novicki DE; Ferrigni RG; Swanson SK Urology; 1996 Jun; 47(6):878-81. PubMed ID: 8677580 [TBL] [Abstract][Full Text] [Related]
11. The variation of percent free prostate-specific antigen determined by two different assays. Yang CR; Ou YC; Horng YY; Lee HS Anticancer Res; 2003; 23(1B):707-11. PubMed ID: 12680171 [TBL] [Abstract][Full Text] [Related]
12. Physiological variation of serum prostate specific antigen in the 4.0 to 10.0 ng./ml. range in male volunteers. Prestigiacomo AF; Stamey TA J Urol; 1996 Jun; 155(6):1977-80. PubMed ID: 8618301 [TBL] [Abstract][Full Text] [Related]
13. The analytical and clinical performance of the new Boehringer Mannheim Enzymun-Test PSA assay for prostate-specific antigen. Blijenberg BG; Eman I; Boevé ER; Mössner E; Uhl W Eur J Clin Chem Clin Biochem; 1995 Jun; 33(6):383-92. PubMed ID: 7578619 [TBL] [Abstract][Full Text] [Related]
14. Predictive properties of serum-prostate-specific antigen testing in a community-based setting. Jacobsen SJ; Bergstralh EJ; Guess HA; Katusic SK; Klee GG; Oesterling JE; Lieber MM Arch Intern Med; 1996 Nov; 156(21):2462-8. PubMed ID: 8944739 [TBL] [Abstract][Full Text] [Related]
15. Age related changes of free and total prostate specific antigen in serum. Wolff JM; Borchers H; Rohde D; Jakse G Anticancer Res; 1999; 19(4A):2629-32. PubMed ID: 10470207 [TBL] [Abstract][Full Text] [Related]
16. The periurethral glands do not significantly influence the serum prostate specific antigen concentration. Oesterling JE; Tekchandani AH; Martin SK; Bergstralh EJ; Reichstein E; Diamandis EP; Yemoto C; Stamey TA J Urol; 1996 May; 155(5):1658-60. PubMed ID: 8627847 [TBL] [Abstract][Full Text] [Related]
17. Serum prostate specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasia. Marks LS; Dorey FJ; Rhodes T; Shery ED; Rittenhouse H; Partin AW; deKernion JB J Urol; 1996 Sep; 156(3):1035-9. PubMed ID: 8709302 [TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen response duration and risk of death for patients with hormone-refractory metastatic prostate cancer. D'Amico AV; Chen MH; Cox MC; Dahut W; Figg WD Urology; 2005 Sep; 66(3):571-6. PubMed ID: 16140080 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the COBAS CORE Immunoassay for measuring prostate-specific antigen (PSA)--multi-centre study results. The PSA Study Group. Schambeck CM Eur J Clin Chem Clin Biochem; 1995 Aug; 33(8):541-7. PubMed ID: 8547440 [TBL] [Abstract][Full Text] [Related]
20. Total prostate specific antigen stability confirmed after long-term storage of serum at -80C. Reed AB; Ankerst DP; Leach RJ; Vipraio G; Thompson IM; Parekh DJ J Urol; 2008 Aug; 180(2):534-7; discussion 537-8. PubMed ID: 18550121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]